Redox modulation of long-term potentiation in the hippocampus via regulation of the glycogen synthase kinase-3β pathway

Free Radical Biology and Medicine

Volumn 45, Issue 7, 2008, Pages 964-970

  Cai, Fei ^a   Wang, Fang ^a,b,c   Lin, Fan Kai ^a   Liu, Chao ^a,b,c   Ma, Li Qun ^a   Liu, Jue ^a   Wu, Wen Ning ^a   Wang, Wei ^a   Wang, Jiang Hua ^a   Chen, Jian Guo ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Free radicals; Glycogen synthase kinase 3 ; Long term potentiation; Redox agents

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); GLYCOGEN SYNTHASE KINASE 3BETA; TOSYLCHLORAMIDE SODIUM; TRIS(2 CARBOXYETHYL)PHOSPHINE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HIPPOCAMPUS; LONG TERM POTENTIATION; MEMBRANE PERMEABILITY; MOLECULAR GENETICS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, WESTERN; EXCITATORY POSTSYNAPTIC POTENTIALS; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; LONG-TERM POTENTIATION; MICROELECTRODES; NEURONAL PLASTICITY; ORGAN CULTURE TECHNIQUES; OXIDANTS; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; REDUCING AGENTS;

RATTUS;

EID: 51349145081     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.06.014     Document Type: Article

References (37)

1. Collie A., and Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci. Biobehav. Rev. 24 (2000) 365-374
2. Butterfield D.A., and Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid b-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32 (2002) 1050-1060
3. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
4. Small D.H., Mok S.S., and Bornstein J.C. Alzheimer's disease and Abeta toxicity: from top to bottom. Nat. Rev. Neurosci. 2 (2001) 595-598
5. Kamsler A., and Segal M. Hydrogen peroxide modulation of synaptic plasticity. J. Neurosci. 23 (2003) 269-276
6. Gozlan H., Khazipov R., Diabira D., and Ben-Ari Y. In CA1 hippocampal neurons, the redox state of NMDA receptors determines LTP expressed by NMDA but not by AMPA receptors. J. Neurophysiol. 73 (1995) 2612-2617
7. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
8. Jope R.S., and Johnson G.V. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29 (2004) 95-102
9. Woodgett J.R. cDNA cloning and properties of glycogen synthase kinase-3. Methods Enzymol. 200 (1991) 564-577
10. Maiese K., and Chong Z.Z. Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease. Restor. Neurol. Neurosci. 22 (2004) 87-104
11. Alvarez A.R., Godoy J.A., Mullendorff K., Olivares G.H., Bronfman M., and Inestrosa N.C. Wnt-3a overcomes b-amyloid toxicity in rat hippocampal neurons. Exp. Cell Res. 297 (2004) 186-196
12. Shin S.Y., Chin B.R., Lee Y.H., and Kim J.H. Involvement of glycogen synthase kinase-3beta in hydrogen peroxide-induced suppression of Tcf/Lef-dependent transcriptional activity. Cell. Signalling 18 (2006) 601-607
13. Hooper C., Markevich V., Plattner F., Killick R., Schofield E., Engel T., Hernandez F., Anderton B., Rosenblum K., Bliss T., Cooke S.F., Avila J., Lucas J.J., Giese K.P., Stephenson J., and Lovestone S. Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. Eur. J. Neurosci. 25 (2007) 81-86
14. Cai F., Li C.R., Wu J.L., Chen J.G., Liu C., Min Q., Yu W., Ouyang C.H., and Chen J.H. Theaflavin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-inflammatory effect and modulation of STAT-1. Mediators Inflammation 2006 (2006) 30490
15. Santarelli L.C., Chen J., Heinemann S.H., and Hoshi T. The beta1 subunit enhances oxidative regulation of large-conductance calcium-activated K+ channels. J. Gen. Physiol. 124 (2004) 357-370
16. Susankova K., Tousova K., Vyklicky L., Teisinger J., and Vlachova V. Reducing and oxidizing agents sensitize heat-activated vanilloid receptor (TRPV1) current. Mol. Pharmacol. 70 (2006) 383-394
17. Lauriault V.V., and O'Brien P.J. Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol. Mol. Pharmacol. 40 (1991) 125-134
18. Hsu M.F., Sun S.P., Chen Y.S., Tsai C.R., Huang L.J., Tsao L.T., Kuo S.C., and Wang J.P. Distinct effects of N-ethylmaleimide on formyl peptide- and cyclopiazonic acid-induced Ca2+ signals through thiol modification in neutrophils. Biochem. Pharmacol. 70 (2005) 1320-1329
19. Pellmar T.C., and Neel K.L. Oxidative damage in the guinea pig hippocampal slice. Free Radic. Biol. Med. 6 (1989) 467-472
20. Gozlan H., Chinestra P., Diabira D., and Ben-Ari Y. NMDA redox site modulates long-term potentiation of NMDA but not of AMPA receptors. Eur. J. Pharmacol. 262 (1994) R3-4
21. Tauck D.L., and Ashbeck G.A. Glycine synergistically potentiates the enhancement of LTP induced by a sulfhydryl reducing agent. Brain Res. 519 (1990) 129-132
22. Kohr G., Eckardt S., Luddens H., Monyer H., and Seeburg P.H. NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 12 (1994) 1031-1040
23. Amato A., Connolly C.N., Moss S.J., and Smart T.G. Modulation of neuronal and recombinant GABAA receptors by redox reagents. J. Physiol. 517 Pt 1 (1999) 35-50
24. Wemmie J.A., Chen J., Askwith C.C., Hruska-Hageman A.M., Price M.P., Nolan B.C., Yoder P.G., Lamani E., Hoshi T., Freeman Jr. J.H., and Welsh M.J. The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory. Neuron 34 (2002) 463-477
25. Chu X.P., Close N., Saugstad J.A., and Xiong Z.G. ASIC1a-specific modulation of acid-sensing ion channels in mouse cortical neurons by redox reagents. J. Neurosci. 26 (2006) 5329-5339
26. Sommer D., Fakata K.L., Swanson S.A., and Stemmer P.M. Modulation of the phosphatase activity of calcineurin by oxidants and antioxidants in vitro. Eur. J. Biochem. 267 (2000) 2312-2322
27. Lovell M.A., Xiong S., Xie C., Davies P., and Markesbery W.R. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. J. Alzheimers Dis. 6 (2004) 659-671 discussion 673-681
28. Embi N., Rylatt D.B., and Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle: separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107 (1980) 519-527
29. Balaraman Y., Limaye A.R., Levey A.I., and Srinivasan S. Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance. Cell. Mol. Life Sci. 63 (2006) 1226-1235
30. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116 (2003) 1175-1186
31. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
32. Hughes K., Nikolakaki E., Plyte S.E., Totty N.F., and Woodgett J.R. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12 (1993) 803-808
33. Pap M., and Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273 (1998) 19929-19932
34. Chen J., Park C.S., and Tang S.J. Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J. Biol. Chem. 281 (2006) 11910-11916
35. Peineau S., Taghibiglou C., Bradley C., Wong T.P., Liu L., Lu J., Lo E., Wu D., Saule E., Bouschet T., Matthews P., Isaac J.T., Bortolotto Z.A., Wang Y.T., and Collingridge G.L. LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53 (2007) 703-717
36. Le Floch N., Rivat C., De Wever O., Bruyneel E., Mareel M., Dale T., and Gespach C. The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling. FASEB J. 19 (2005) 144-146
37. Jope R.S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24 (2003) 441-443